WallStreetZenWallStreetZen

NYSEMKT: IGC
Igc Pharma Inc Earnings & Revenue

OverviewEarnings
DividendOwnership

IGC past revenue growth

How has IGC's revenue growth performed historically?
Company
40.09%
Industry
145.73%
Market
17.2%
IGC's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
IGC's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
IGC's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

IGC earnings and revenue history

Current Revenue
$1.2M
Current Earnings
-$14.1M
Current Profit Margin
-1,163.2%

IGC Return on Equity

Current Company
-110.4%
Current Industry
-63.5%
Current Market
188%
IGC's Return on Equity (-110.4%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when IGC announces earnings.

IGC Return on Assets

Current Company
-93.3%
Current Industry
2.9%
IGC is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

IGC Return on Capital Employed

Current Company
-151.72%
Current Industry
19.5%
IGC's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

IGC vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
IGC$1.22M-$13.52M-$14.15M-23.74%N/A
ACST$0.00-$48.89M-$38.77M-100.00%N/A
SRZN$0.00-$39.86M-$43.04M-100.00%N/A
PTN$7.10M-$31.25M-$31.59M-24.85%N/A
ENLV$0.00-$28.56M-$29.07MN/AN/A
View Top Biotech Stocks

IGC earnings dates

Next earnings date
Jun 20, 2024

Igc Pharma Earnings & Revenue FAQ

What were IGC's earnings last quarter?

On Invalid Date, Igc Pharma (NYSEMKT: IGC) reported Q4 2023 earnings per share (EPS) of -$0.09, up 125% year over year. Total Igc Pharma earnings for the quarter were -$5.59 million. In the same quarter last year, Igc Pharma's earnings per share (EPS) was -$0.04.

If you're new to stock investing, here's how to buy Igc Pharma stock.

What was IGC's earnings growth in the past year?

As of Q2 2024, Igc Pharma's earnings has grown year over year. Igc Pharma's earnings in the past year totalled -$14.15 million.

What is IGC's earnings date?

Igc Pharma's earnings date is Invalid Date. Add IGC to your watchlist to be reminded of IGC's next earnings announcement.

What was IGC's revenue last quarter?

On Invalid Date, Igc Pharma (NYSEMKT: IGC) reported Q4 2023 revenue of $204.00 thousand up 38.55% year over year. In the same quarter last year, Igc Pharma's revenue was $332.00 thousand.

What was IGC's revenue growth in the past year?

As of Q2 2024, Igc Pharma's revenue has grown 40.09% year over year. This is 105.64 percentage points lower than the US Biotechnology industry revenue growth rate of 145.73%. Igc Pharma's revenue in the past year totalled $1.22 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.